» Articles » PMID: 10367824

Smallpox As a Biological Weapon: Medical and Public Health Management. Working Group on Civilian Biodefense

Overview
Journal JAMA
Specialty General Medicine
Date 1999 Jun 15
PMID 10367824
Citations 212
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To develop consensus-based recommendations for measures to be taken by medical and public health professionals following the use of smallpox as a biological weapon against a civilian population.

Participants: The working group included 21 representatives from staff of major medical centers and research, government, military, public health, and emergency management institutions and agencies. Evidence The first author (D.A.H.) conducted a literature search in conjunction with the preparation of another publication on smallpox as well as this article. The literature identified was reviewed and opinions were sought from experts in the diagnosis and management of smallpox, including members of the working group.

Consensus Process: The first draft of the consensus statement was a synthesis of information obtained in the evidence-gathering process. Members of the working group provided formal written comments that were incorporated into the second draft of the statement. The working group reviewed the second draft on October 30, 1998. No significant disagreements existed and comments were incorporated into a third draft. The fourth and final statement incorporates all relevant evidence obtained by the literature search in conjunction with final consensus recommendations supported by all working group members.

Conclusions: Specific recommendations are made regarding smallpox vaccination, therapy, postexposure isolation and infection control, hospital epidemiology and infection control, home care, decontamination of the environment, and additional research needs. In the event of an actual release of smallpox and subsequent epidemic, early detection, isolation of infected individuals, surveillance of contacts, and a focused selective vaccination program will be the essential items of an effective control program.

Citing Articles

Jenner's Legacy: How Edward Jenner's Smallpox Vaccine Changed Public Health.

Ahamed Vp A, Choudhari S, Mudey A, Joshi A Cureus. 2024; 16(9):e68594.

PMID: 39371745 PMC: 11450354. DOI: 10.7759/cureus.68594.


From ancient remedies to modern miracles: tracing the evolution of vaccines and their impact on public health.

Kajal , Pandey A, Mishra S 3 Biotech. 2024; 14(10):242.

PMID: 39319014 PMC: 11417089. DOI: 10.1007/s13205-024-04075-7.


Tecovirimat Use under Expanded Access to Treat Mpox in the United States, 2022-2023.

Yu P, Elmor R, Muhammad K, Yu Y, Rao A NEJM Evid. 2024; 3(10):EVIDoa2400189.

PMID: 39270215 PMC: 11421955. DOI: 10.1056/EVIDoa2400189.


A Pseudovirus Nanoparticle Displaying the Vaccinia Virus L1 Protein Elicited High Neutralizing Antibody Titers and Provided Complete Protection to Mice against Mortality Caused by a Vaccinia Virus Challenge.

Huang P, Xia M, Vago F, Jiang W, Tan M Vaccines (Basel). 2024; 12(8).

PMID: 39203972 PMC: 11359793. DOI: 10.3390/vaccines12080846.


Evaluating Two Educational Interventions for Enhancing COVID-19 Knowledge and Attitudes in a Sample American Indian/Alaska Native Population.

Takagi M, Rhodes S, Kim J, King M, Soukar S, Martin C Vaccines (Basel). 2024; 12(7).

PMID: 39066425 PMC: 11281502. DOI: 10.3390/vaccines12070787.